GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
HR 942American Research and Competitiveness Act of 2011provisions relating to the research and development tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Trade (domestic/foreign) TRD
HR 3080Korea Free Trade Agreement - provisions related to intellectual property, market access and public health Trans-Pacific Strategic Economic Partnership Agreement (TPP) - provisions related to intellectual property, market access and public health
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
S 27 Preserve Access to Affordable Generics Act - provisions related to patent settlements HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - provisions relating to authorized generics HR 2182,S 1734 Generating Antibiotic Incentives Now Act of 2011 - provisions related to antibiotics and incentives HR 3261 Stop Online Piracy Act - provisions related to anti-counterfeiting S 373 The Fair Prescription Drug Competition Act - provisions related to authorized generics S 968 Preventing Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 - provisions related to anti-counterfeiting
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
PL 111-148, PL 111-152Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions HR 2405, S 1855 Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies S 1002 Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES)drug safety HR 1483 The Drug Safety Enhancement Act of 2011 - drug safety standards HR 1930, S 1799 Access to Appropriate Immunizations for Veterans Act of 2011 - extending VA performance measure to include all federally recommended vaccine HR 3202 Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S 3397 Secure and Responsible Drug Disposal Act - provisions related to safe drug disposal S 319 Pharmaceutical Market Access and Drug Safety Act of 2011 - provisions related to drug importation HR 2245, S 296 Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages HR 2939 Pharmaceutical Stewardship Act of 2011 - provisions related to drug safety ADDENDUM/General Lobbying Issue Area - Prescription Drug User Fee Act (currently unassigned) - issues related to reauthorization of the Prescription Drug User Fee Act HR 2529, S 1368 Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S 1584 Drug Safety and Accountability Act of 2011- provisions related to drug safety ADDENDUM/General Lobbying Issue Area - Federal Food, Drug, and Cosmetic Act (currently unassigned) - section related to FDA and regulation of nicotine replacement therapies S. 1699 Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates S. 1752 Freedom to Breath Act of 2011 - provisions relating to the removal of Essential-Use Designation for epinephrine.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
HR 999Medicare Prescription Drug Savings and Choice Act of 2011- provisions related to Medicare Part D HR 2190Medicare Drug Savings Act of 2011 - provisions related to Medicare Part D HR 2248Medicare Prescription Drug Price Negotiation Act of 2011 - provision related to Medicare Part D H.R. 3765Temporary Payroll Tax Cut Continuation Act of 2011provisions related to Medicare S 31Prescription Drug and Health Improvement Act of 2011- provisions related to Medicare Part D S 44Medicare Prescription Drug Price Negotiation Act of 2011- provisions related to Medicare Part D HR 452 Medicare Decisions Accountability Act - provisions related to the Independent Payment Advisory Board (IPAB) S 365Budget Control Act of 2011 - deficit reduction issues related to Medicare and Medicaid S 560Medicare Prescription Drug Savings and Choice Act of 2011-provisions related to Medicare Part D S 668Health Care Bureaucrats Elimination Actprovisions related to the Independent Payment Advisory Board (IPAB) S 1206 Medicare Prescription Drug Savings Act of 2011- provisions related to Medicare Part D S 1251 Medicare and Medicaid FAST Act - provisions related to Part D issues HR 1063 Strengthening Medicare & Repaying Taxpayers Act of 2011- provisions relating to reform of Secondary Payer rules
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
HR 2112 Fiscal Year 2012 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act - provisions pertaining to Ryan White CARE Act, FDA funding HR 2017 The Department of Homeland Security Appropriations Act - provisions pertaining to Customs and Border Protection HR 2608 Fiscal Year 2012 Continuing Appropriations Act - FDA funding and related provisions S 1599 Fiscal Year 2012 Labor-HHS-Education Appropriations; FY 2012 HHS Budget Request; provisions relating to Vaccine Section 317 program, Ryan White CARE Act HR 2055 Fiscal Year 2012 Consolidated Appropriations Act - provisions relating to health and trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| SARA HART WEIR | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.